Only people with lung cancer that tests positive for a particular genetic variation are candidates for treatment with Pfizer's twice-a-day cancer pill called Xalkori. Most of those who qualified in clinical tests saw dramatic shrinkage of their tumors
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/08/30/140053471/lung-cancer-pill-holds-promise-for-those-who-pass-test?ft=1&f=103537970
Posted
Aug 30 2011, 05:11 AM
by
NPR Blogs: Shots - Health Blog